Novo Nordisk, U.S. biotech company team up to create obesity pills
Novo Nordisk will pay all the research and development costs for the project to develop new obesity pills. Photo by Towfiqu barbhuiya/ Pexels
May 16 (UPI) -- Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.
The deal could be worth up to $2.2 billion for Septerna. This includes more than $200 million in upfront and short-term milestone payments, plus future rewards tied to research, development and sales. Septerna will also get royalties on any future product sales, The Wall Street Journal reported.
Novo Nordisk will pay all the research and development costs for the project.
The U.S. biotech company has developed a platform that finds and develops drugs that target special proteins called G protein-coupled receptors.
These proteins help pass chemicals from outside cells to the inside. Many major drugs on the market today also target GPCRs.
Novo Nordisk's best-known drug, Wegovy, targets a GPCR called GLP-1. Eli Lilly's popular weight-loss drug Zepbound targets both GLP-1 and another GPCR called GIP.
"Septerna has demonstrated strong capabilities in GPCR drug discovery," Marcus Schindler, chief scientific officer at Novo Nordisk, told The Wall Street Journal.
"We are excited about the opportunity to develop oral small molecule medicines directed at multiple targets," he added.
The two companies plan four programs to create pills that target GPCRs including GLP-1, GIP and glucagon -- which are important proteins involved in blood sugar and appetite control, The Journal said.
Right now, leading weight-loss drugs must be injected into the body. Pill versions could make the drugs more convenient for patients and easier to ship and store.
About one-third of drugs approved by the U.S. Food and Drug Administration target GPCRs, according to Novo Nordisk. But an estimated 75% of GPCR targets have not yet been used in medicine, meaning there's still a big opportunity for discovery.
Septerna's stock jumped 69% in premarket trading after the deal was announced. Novo Nordisk's stock rose 1.2% in European trading.
More information
The Mayo Clinic has more on prescription weight-loss drugs.
Copyright © 2025 HealthDay. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
OpenAI chairman's career advice? Remember what Eric Schmidt told Sheryl Sandberg about joining Google.
OpenAI chairman Bret Taylor believes you shouldn't allow pride to stand in the way of success. If someone offers you a seat on the "rocket ship," you don't ask which seat, you get on, he said, recalling Eric Schmidt's conversation with Sheryl Sandberg. Flexibility and perspective are key in both your career and life, he said on an episode of the "Grit" podcast. Bret Taylor, the chairman of OpenAI, believes that if you have the chance to attach yourself to success, you shouldn't let ego get in the way. "I think this is the quote I always heard, was Eric Schmidt to Sheryl Sandberg: 'If someone offers you a seat on a rocket ship, don't ask what seat,' you know? I like that philosophy of life," Taylor said on an episode of "Grit." At the time, Sandberg, who would famously later become Facebook's chief operations officer, was deciding whether or not to join a different tech company: Google. Google was a tiny fraction of the size in 2001, with fewer than 300 people. Eric Schmidt had recently been brought on by cofounders Sergey Brin and Larry Page to be CEO. Sandberg talked about her conversation with Schmidt during a speech to Harvard students. "So I sat down with Eric Schmidt, who had just become the CEO, and I showed him the spreadsheet and I said, this job meets none of my criteria," Sandberg recalled. "He put his hand on my spreadsheet and he looked at me and said, 'Don't be an idiot. Get on a rocket ship. When companies are growing quickly and they are having a lot of impact, careers take care of themselves. If you're offered a seat on a rocket ship, don't ask what seat. Just get on.'" Sandberg did end up taking the job, and joined as the general manager of Google's business unit, which had four people at the time. "I do think, especially in Silicon Valley, there's just unique moments, and you just have to be self-aware and aware of the market," OpenAI's Taylor said. Beyond being ready to jump at opportunity wherever it comes knocking at your door, remaining broadly flexible is also important, he added. "Most of the unhappiest people I know are rigidly following a plan and not observant of their own happiness or observant of the opportunities around them," Taylor said. "I actually think that a big part of life is recognizing when there's a unique opportunity that you didn't plan for, and asking yourself the question, 'Should I change my plans?' Whether that's in your personal life or your professional life." Taylor's own career spans Big Tech and startups alike — from leading the team that helped create Google Maps and acting as co-CEO of Salesforce, to founding his own AI company, Sierra. "The idea of sitting on the sidelines, and drinking a mai tai on a beach, doesn't give me joy at all," he said. "I want to build." Just as Taylor was leaving Salesforce, ChatGPT was released. After a conversation over lunch with his cofounder, Clay Bavor, Taylor said the decision to start Sierra was set. But even if he wasn't heading this particular company, he added, he would still be working in an adjacent sphere. "I would be building open source software if not running a company right now, because I just want to work in the technology and help shape it," Taylor said. "Because it's the most exciting technology of my memory, and I want to play a part in shaping how we all use it." That's another key piece of Taylor's personal philosophy: being as involved as possible in shaping the trajectory of the world. "There's this Alan Kay quote: 'The best way to predict the future is to invent it.' And that is like, my operating principle," he said. "I want to impact the future, and I want to help invent it." Read the original article on Business Insider
Yahoo
30 minutes ago
- Yahoo
Retail Investors Pile Into Tesla (TSLA) After 14% Plunge on Trump-Musk Rift
Retail traders aggressively bought Tesla (TSLA, Financials) shares Thursday after the stock plunged 14.3%its 11th worst day since going publicamid a very public feud between CEO Elon Musk and U.S. President Donald Trump. The stock rebounded 5.6% Friday to around $299.14. Vanda Research data showed self-directed investors net purchased $201.3 million of Tesla shares after trading $2.6 billion in volume, making it the second-most bought stock by that group. Traders also poured $41.5 million into the Direxion Daily 2x Bull ETF, a leveraged fund that tracks Tesla. Despite the sharp selloff, the options market showed little panic. Tesla's 30-day implied volatility rose to 77, up from earlier levels but well below the 106.1 peak in April. Chris Murphy of Susquehanna said some traders capitalized on the volatility by selling puts, a sign of confidence that the slide might stabilize. Buy the dip is the overwhelming sentiment, said Marco Iachini of Vanda, citing social media scans on Reddit and X, where Tesla remains a retail investor favorite. Tesla shares had surged 90% following Trump's election win in November, but are now down about 37% from their Dec. 17 peak. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
32 minutes ago
- Yahoo
Amazon Eyes AI-Powered Humanoid Robots for Last-Mile Edge
Amazon (NASDAQ:AMZN) stock popped about 2.7% yesterday after word got out that the e-commerce giant is quietly building a humanoid park in San Francisco to experiment with AI-powered robots for deliveries. Warning! GuruFocus has detected 2 Warning Sign with AMZN. Instead of relying solely on its 750,000 warehouse bots, Amazon is now eyeing humanoid prototypessome coming from China's Unitreethat can literally hop out of a Rivian (RIVN) delivery van to drop packages at your doorstep. Right now, engineers are fine-tuning navigation, object handling and safety systems in a mock urban environment, complete with a single Rivian van parked among obstacles. Meanwhile, over at Amazon's Lab126 in Sunnyvale, a fresh agentic AI team is working on getting these robots to understand and act on natural language commandsimagine telling a bot, Pick up that package and leave it by the back door and having it do just that. All of this is part of Amazon's broader push to shave billions off its fulfillment and delivery bills (which topped $60 billion last year) and stay a step ahead of rivals like Walmart (NYSE:WMT) and FedEx (NYSE:FDX). While timelines are still fuzzy, CEO Andy Jassy hinted that pilot tests could roll out in select cities later this year. Investors should care because if these humanoid bots make it from test park to real-world routes, Amazon could cut costs, boost delivery speeds and create a new benchmark in last-mile logistics. This article first appeared on GuruFocus.
